Nicozet may be available in the countries listed below.
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Nicozet in the following countries:
International Drug Name Search
Dimazon may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Furosemide is reported as an ingredient of Dimazon in the following countries:
Furosemide diolamine (a derivative of Furosemide) is reported as an ingredient of Dimazon in the following countries:
Furosemide monoethanolamine (a derivative of Furosemide) is reported as an ingredient of Dimazon in the following countries:
International Drug Name Search
Etoposide DBL may be available in the countries listed below.
Etoposide is reported as an ingredient of Etoposide DBL in the following countries:
International Drug Name Search
Naproxen A may be available in the countries listed below.
Naproxen is reported as an ingredient of Naproxen A in the following countries:
International Drug Name Search
Hydase is a brand name of hyaluronidase, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Hydase available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Hydase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Hydase.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Rec.INN
0009007-72-1
FeIIIw([C6-H10-O5]a-C6-H11-O7)x(O-H)y-Oz·(H2O)n
Antianemic agent, treatment of iron deficiency
4-O-Poly[α-D-glucopyranosyl(1-->4)]-D-gluconsäure-Eisen(III)hydroxid
Iron(3+) hydroxide oxide poly-(1->4)-α-D-glucopyranosyl-(1->4)-D-gluconate hydrate (USAN)
Poly[D-glucopyranosyl(1->4)]-D-gluconic acid complex of hydrated iron(III) oxide (WHO)
Polynuclear iron (III)-hydroxide 4(R)-(poly-(1->4)-O-α-D-glucopyranosyl)-oxy-2(R),3(S),5(R), 6-tetrahydroxyhexanoate (USAN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Protin-P may be available in the countries listed below.
Pantoprazole is reported as an ingredient of Protin-P in the following countries:
International Drug Name Search
Cutacelan may be available in the countries listed below.
Azelaic Acid is reported as an ingredient of Cutacelan in the following countries:
International Drug Name Search
Nizatidine PCH may be available in the countries listed below.
Nizatidine is reported as an ingredient of Nizatidine PCH in the following countries:
International Drug Name Search
